NCT02377895View on ClinicalTrials.gov

Allergen Biocube Study Evaluating Efficacy and Safety of Nasapaque Nasal Solution in Adult Subjects With Allergic Rhinitis

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

73

Participants

Timeline

Start Date

March 31, 2015

Primary Completion Date

July 31, 2015

Study Completion Date

July 31, 2015

Conditions
Seasonal Allergic Rhinitis
Interventions
DRUG

Nasapaque Nasal Solution

DRUG

Placebo Saline Nasal Solution

Sponsors
All Listed Sponsors
collaborator

ORA, Inc.

INDUSTRY

lead

3E Therapeutics Corporation

INDUSTRY